Venous thrombo-embolism as a complication of cros… [Andrologia. 2013] – PubMed – NCBI
Administration of cross-sex hormones to male-to-female transsexual subjects, usually oestrogens + often anti-androgens, such as cyproterone acetate, carries a risk of venous thromboembolism (VTE). VTE usually occurs …
A review article of findings related to VTE and MtF HRT. It’s one of those unpleasant side-effects that transwomen need to be aware of, especially if they’re going the self-dosing route.
Interestingly, the article also makes the recommendation that transdermal estrogen (i.e. skin patches) is the best delivery method for reducing VTE risks. I’ve been seeing more and more references to patches in the personal blogs and Twitter feeds of transwomen, so perhaps this is something that doctors are learning as they go.